Knight Therapeutics | GUD - Market Capitalization


Knight Therapeutics reported CAD956.06M in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 46M 39M Jun/2026
Aurora Cannabis CAD 327.21M 142.93M Dec/2025
Avita Medical AUD 105.47M 35.32M Dec/2025
Canopy Growth CAD 656.46M 124.89M Dec/2025
Cronos Group USD 958.02M 45.05M Mar/2026
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
IQVIA Holdings USD 28.63B 9.76B Mar/2026
Moderna USD 20.15B 8.53B Mar/2026
Organigram Holdings CAD 312.16M 66.64M Dec/2025
Revvity USD 9.94B 1.03B Mar/2026
Tectonic Therapeutic USD 390M 96M Dec/2025
Viatris USD 15.73B 1.39B Mar/2026